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Abstract
Background: There have been inconsistent conclusions regarding the levels of inflammatory mediators in saliva and
serum among people with or without periodontal disease. Although pre-conception has been put forward as the
optimal time for the periodontal treatment in order to improving pregnancy outcomes, few studies have been
conducted to examine inflammatory mediators in saliva and serum among pre-conception women.
Methods: Pre-conception women were recruited between January 2012 and December 2014. Women were provided
with an oral health examination to detect periodontal disease. Salivary and serum samples were collected at the same
of examination. Inflammatory mediators includinginterleukin-1 beta (IL-1β), IL-6, tumor necrosis factor alpha (TNF-α)
and beta-glucuronidase (β–glucuronidase) were tested and analyzed among women with overall periodontal disease
(n = 442) or moderate/severe periodontal disease (n = 247). Results were compared to that in women with a healthy
periodontium (n = 91).
Results: Significantly increased concentrations of inflammatory mediators of IL-1β, IL-6, TNF-α and β-glucuronidase in
saliva and IL-1β, β-glucuronidase and TNF-α in serum were found among pre-conception women with moderate/
severe periodontal disease, compared with women without periodontal disease. Significantly increased levels were also
found in all the above saliva inflammatory mediators and in serum IL-1β and TNF-α among women with overall
periodontal disease. The levels of all inflammatory mediators in saliva and almost all inflammatory mediators
except IL-6 in serum significantly increased with severity of periodontal disease.
Conclusion: Periodontal disease is highly associated with the elevated levels of inflammatory mediators in saliva
and some mediators in serum among pre-conception women.
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Background
Periodontal disease, as a persistent infection of Gram-
negative bacteria, has been found to be associated with
systemic diseases such as cardiovascular diseases, stroke,
diabetes mellitus and adverse pregnancy outcomes [1–3].
The periodontal pathogens and their virulence products
not only damage the periodontal tissues, activating a local
inflammatory response, but also trigger the systematic
inflammatory response and ectopic infections through
hematogenous dissemination [4]. This downstream effect
by bacterial substances and host-derived inflammatory
mediators is capable of initiating and promoting systemic
diseases including adverse pregnancy outcomes [4, 5].
Levels of inflammatory mediators such as interleukin-1β
(IL-1β), IL-6 and tumor necrosis factor alpha (TNF-α)
in gingival crevicular fluid, saliva or serum are usually
regarded as a reflection of host’s local and systemic in-
flammatory response [6–9].
Systematic reviews have shown an association
between periodontal disease and increased risk of
several adverse pregnancy outcomes including low birth
weight, pre-term birth, gestational diabetes mellitus
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and preeclampsia [10, 11]. Considering the possible side
effects that result from periodontal treatment during
pregnancy, pre-conception has been put forward as the
optimal time for the periodontal treatment in the
purpose of improving pregnancy outcomes [5, 12].
Studies have been performed to explore the associ-
ation between periodontal disease and systemic diseases,
by detecting whether periodontal disease is linked with
the levels of inflammatory mediators in mouth and
blood. However, there have been inconsistent conclu-
sions regarding the levels of inflammatory mediators
among people with or without periodontal disease. Some
studies showed significantly higher levels of IL-1β, IL-6
in the gingival crevicular fluid, saliva or in serum [6, 7],
while others did not show such differences [8, 9]. Fur-
thermore, very few studies examined the levels of local
and systemic inflammatory mediators at the same time,
leading to the weak evidence explaining the association
between periodontal disease and pregnant outcomes.
This paper aims to compare the levels of local and sys-
temic inflammatory mediators in pre-conception women
with or without periodontal disease, using the baseline
data of a randomized controlled trial of pre-conception
treatment for periodontal disease to improve pregnancy
and birth outcomes (Trial registration number: ChiCTR-
TRC-12001913) [12]. The findings will contribute to un-
derstanding the associations of chronic infectious diseases
such as periodontal disease and the development of
systemic disease including adverse pregnancy outcomes.
Methods
Participants and recruitment
From January 2012 to December 2014, preconception
women were recruited at the Maternal and Child Health
Care Hospital, in Changzhou, China, a tertiary MCH
hospital, with both pre-conception health clinic and den-
tal clinic. The annual number of delivery is around 9000,
covering more than 70% of deliveries in the city [12].
Women were approached by the research nurse in the
pre-conception clinic and were invited to participate in
the study if they were at least 18 years old, with the de-
sire of being pregnant within 1 year, planning to deliver
at the recruiting hospital, having more than 20 teeth,
without systematic disease such as cardiovascular dis-
ease, diabetes and immunodeficiency disease, without
contraindication to probing in a dental examination, and
not having received periodontal treatment within the
past 6 months.
After the informed consent, eligible women were
interviewed to complete a questionnaire containing
demographic and periodontal disease relevant informa-
tion. Then women were offered with a free full-mouth den-
tal examination for determining periodontal disease. The
research received ethical approval from the Institutional
Review Board of the School of Public Health, Fudan
University, Shanghai, China. Written informed consent was
obtained from each participant before the questionnaire
survey and dental examination.
Definition and measurement of periodontal disease
A full mouth dental examination was performed on each
woman to determine periodontal disease. For each tooth,
six sites (mesio-buccal, mesio-lingual, disto-buccal, disto-
lingual, mid-buccal and mid-lingual) were probed by using
a manual UNC-15 probe [11]. The dentist who performed
dental examination had been trained and calibrated by a
dentist who specializes in periodontal disease. All exami-
nation was completed by the same dentist in the hospital
to avoid inter-observer measurement bias.
We used indicators combing probing depth (PD) and
clinical attachment loss (CAL) over a certain threshold
as a diagnosis of periodontal disease [1, 12]. Referring to
the diagnostic criteria used by Offenbacher et al. [13],
periodontal disease in this study was defined as: the
overall periodontal disease as a presence of any site exhi-
biting PD > 3 mm or CAL > 3 mm; the moderate peri-
odontal disease as the presence of 4 or more sites with
PD > 3 mm; severe periodontal disease as 4 or more sites
with PD ≥ 5 mm. Those who met the diagnosis criteria for
periodontal disease, but not the moderate or severe degree,
were categorized as the mild periodontal disease. Bleeding




Saliva was collected before the dental examination. The
whole expectorated saliva, without stimulation, was col-
lected from each participant using an adapted version of
the method described by Miller et al. [14]. Women were
asked to firstly rinse their mouths with tap water, wait
for 5 min, and then expectorate whole saliva into a clean
container for 5 ml within 10 min. The research nurse
moved the saliva to a sterile tube. The samples was im-
mediately centrifuged, and the upper clear portion was
kept and frozen at −80 °C.
Blood sample collection
At the same appointment as the dental examination,
5 ml extra blood was drawn by venipuncture. The blood
samples were centrifuged for 10 min at 3000 revolu-
tions/min and the serum put in a sterile tube and kept
at −80 °C.
Lab test
One technologist who was blinded to the diagnosis of peri-
odontal disease completed all the lab tests in the partici-
pating hospital. The concentration of each inflammatory
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mediators includingIL-1β, IL-6, TNF-α and beta-
glucuronidase (β–glucuronidase) were tested using en-
zyme immunosorbent assays (ELISA) kits (Shanghai
Biosh Biological Technology Co., Ltd, China) according
to manufacturer’s directions.
Data analysis
Women’s body mass index (BMI) was calculated as
weight (kg)/height2 (metres2). Overweight was defined as
BMI ≥ 25 [15]. Perceived Stress Scale with 14 items was
used to measure women’s stress [16, 17]. Each item was
scored 0–4 according to women’s answer and the total
score ranged from 0 to 56. Pre-conception women were
divided to the “high” or the “low” stress groups, accor-
ding to the median score of 24.
All data were input using Epidata 3.1 and double
checked for correctness. Statistical analyses were carried
out using the Statistical Package for Social Sciences
(SPSS) for windows version 17.0. The Pearson Chi-square
test was used for categorical outcomes and t-test was used
for continuous variables. Inflammatory mediators were
checked for normality and log-transformed if significantly
non-normal. Multivariate linear regression was performed
for determining the association between periodontal dis-
ease and inflammatory mediators, with adjustment for
women’s age, educational level, employment status,
monthly family income, parity, family periodontal disease
history, oral health insurance, BMI, stress score, oral
hygiene. These factors were showed to be related to
periodontal disease in literatures and levels of inflamma-
tory mediators in our study [18–20]. In addition, severity
of periodontal disease among pre-conception women were
considered as an ordinal variable (coded as 1 through 3
representing healthy periodontium, mild periodontal
disease and moderate/severe periodontal disease respec-
tively) in the multiple linear regression model to test the
linear trend.
Result
Biological specimens, including saliva and blood sam-
ples, were taken from 533 preconception women. The
average age of pre-conception women was 26 years old.
Most of women (86.7%, 462/533) had college or above
education level and 82.7% (441/533) were employed.
Around 97.0% (517/533) women reported monthly
family income was above 4000 RMB (the minimum
monthly income criterion, ~USD $615). Most of women
(87.1%, 464/533) were primiparas. 48.2% (257/533)
women reported at least one of their family members
with periodontal disease. Only 5.8% (31/533) of women
reported the oral health care that was entirely or partly
covered by health insurance (Table 1). A total of 80.3%
(428/533) women reported tooth brushing at least twice
per day. Only 8.4% (45/533) women were overweight.
Seventy-five of the 533 women did not have any site
with BOP. The sites with BOP ranged from 1 to 108
among the rest of women, equal to 0.5–66.7% of the
sites. Using the combined diagnostic criteria of PD and
CAL, 82.9% (442/533) of the women were diagnosed
with periodontal disease and 17.1% (91/533) as having a
healthy periodontium. Among women with periodontal
disease, 55.0% (243/442) was diagnosed with moderate
and 0.9% (4/442) with severe periodontal disease; the
remaining 44.1% were (195/442) mild (Table 2). There
was no significant difference on any of socioeconomic
status or periodontal relevant factors in women either
with overall periodontal disease or with moderate/severe
periodontal disease compared to women without peri-
odontal disease (Table 1).
Table 3 shows the difference of inflammatory media-
tors in saliva and serum among women with periodontal
disease, women with moderate/severe periodontal dis-
ease and women without periodontal disease. Compared
with women without periodontal disease, all of the in-
flammatory mediators in saliva were significantly higher
among women with overall periodontal disease or with
moderate/severe periodontal disease. Serum IL-1β and
TNF-α levels were significantly higher in women with
overall periodontal disease compared with women without
periodontal disease. Serum IL-1β, β–glucuronidase and
TNF-αwere significantly higher in women with moderate/
severe periodontal disease, compared with women without
periodontal disease.
Table 4 presents ratios of the mean levels of inflam-
matory mediators in women with periodontal disease,
women with moderate/severe periodontal disease over
the levels of women without periodontal disease (refe-
rence group), after adjusting for confounding factors
using multivariable linear regression. In general, the
adjusted ratios showed the similar trend as compared
with the crude ratios. Compared with women without
periodontal disease, levels of all inflammatory media-
tors in saliva were 1.10–1.36 times higher; and levels
in serum were 1.12–1.49 times higher in women with
overall periodontal disease. The adjusted ratios were
even higher when comparing women with moderate/
severe periodontal disease to women without perio-
dontal disease. Levels of all inflammatory mediators in
saliva were 1.13–1.40 times higher, and levels in serum
were 1.15–1.62 times higher in women with moderate/
severe periodontal disease compared with the refe-
rence group.
A significantly positive linear trend was found between
the degree of periodontal morbidity and inflammatory
mediators (Table 5). The levels of all inflammatory me-
diators in saliva and levels of all inflammatory mediators
except IL-6 in serum significantly increased with severity
of periodontal disease.
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Discussion
The results of our study showed, compared with women
without periodontal disease, pre-conception women with
moderate/severe periodontal disease had significantly
increased concentrations of inflammatory mediators of
IL-1β, IL-6, β-glucuronidase and TNF-α in saliva and
IL-1β, β-glucuronidase and TNF-α in serum. Signifi-
cantly increased levels were also found in all the above
salivary inflammatory mediators and in serum IL-1β and
TNF-α among women with overall periodontal disease,
compared with women without periodontal disease. The
Table 1 Characteristics of study participants








periodontal disease n (%)
(N = 247)
Age (mean ± SD) 26.53 ± 2.96 26.86 ± 3.63 26.61 ± 3.45 0.41 0.84
Education level
Junior middle school and below 5 (5.5) 26 (5.9) 14 (5.7) 0.38* 0.31*
Senior middle school 10 (11.0) 30 (6.8) 15 (6.1)
College and above 76 (83.5) 386 (87.3) 218 (88.3)
Family income per month
< 4,000RMBc 2 (2.2) 14 (3.2) 9 (3.6) 0.62* 0.51*
≥ 4,000RMBc 89 (97.8) 428 (96.8) 238 (96.4)
Employment status
Unemployed 16 (17.6) 76 (17.2) 43 (17.4) 0.93* 0.97*
Employed 75 (82.4) 366 (82.8) 204 (82.6)
BMI kg/m2 (mean ± SD) 20.91 ± 2.48 20.80 ± 2.58 20.80 ± 2.65 0.71* 0.73*
Periodontitis family history
No 47 (51.6) 210 (47.5) 117 (47.4) 0.74* 0.46*
Yes 11 (12.1) 53 (12.0) 23 (9.3)
unknown 33 (36.3) 179 (40.5) 107 (43.3)
Parity
0 80 (87.9) 384 (86.9) 213 (86.2) 0.79* 0.69*
1 or 2 11 (12.1) 58 (13.1) 34 (13.8)
Oral health insurance
No 86 (94.5) 416 (94.1) 234 (94.7) 0.89* 0.93*
Yes 5 (5.5) 26 (5.9) 13 (5.3)
Oral hygiene
Teeth brush ≥ 2 times per day 17 (18.7) 88 (19.9) 54 (21.9) 0.79* 0.52*
Teeth brush < 2 times per day 74 (81.3) 354 (80.1) 193 (78.1)
Smoking
No 90 (98.9) 437 (98.9) 244 (98.8) 0.98** 0.93**
Yes 1 (1.1) 5 (1.1) 3 (1.2)
Stress (mean ± SD) 23.80 ± 5.81 23.86 ± 5.94 24.37 ± 5.39 0.93* 0.40*
*Chi-square or t-test; ** Fisher’s exact test
acomparison between women with overall periodontal disease and non-periodontal disease
bcomparison between women with moderate/severe periodontal disease and non-periodontal disease
c1 RMB ~0.15 USD
Table 2 Categories of periodontal disease
Indicator N (%)
Women with periodontal disease 442 (82.9)
Women with moderate periodontal disease 243 (55.0)
Women with severe periodontal disease 4 (0.9%)
Women with at least one site of BOP 458 (85.9)
Jiang et al. BMC Oral Health  (2016) 16:131 Page 4 of 7
positive linear trend was found between the degree of
periodontal morbidity and the levels of inflammatory
mediators except serum IL-6.
Socioeconomic and medical/dental factors were compar-
able between women with and without periodontal disease,
and also between women those with moderate or severe
periodontal disease and without periodontal disease. The
findings showed the levels of inflammatory mediators in
saliva were highly correlated with periodontal disease, and
also significantly associated with the severity of periodontal
morbidity. This suggests the critical role of inflammatory
host response of periodontal disease, which was also indi-
cated by previous study [21]. The IL-1β, IL-6 and TNF-α
have been defined as the subpopulation of T helper 1
lymphocytes and have proinflammatory actions [22]. β-
glucuronidase is an acid hydrolase found in PMN lyso-
somes, a marker for primary granule release produced by
inflammatory cells. The increased salivary β-glucuronidase
level was regarded as an important marker of periodontal
destruction [23]. This might be the reason why the
above inflammatory mediators were higher in women
with periodontal disease compared to women with a
healthy periodontium. The elevated concentrations of
serum IL-1β, β-glucuronidase, TNF-α accompanying
with the saliva mediators suggested periodontal disease
might be one of the factors triggering a systemic in-
flammatory response. Studies have shown high IL-1β
and TNF-α concentration in serum or amniotic fluid
Table 3 Inflammatory mediator level among women with overall, moderate/severe and without periodontal disease
Inflammatory mediator Women overall periodontal










IL-1β (pg/ml) 92.76 ± 1.16 94.63 ± 1.16 75.19 ± 1.27 <0.001 <0.001
β-glucuronidase (U/L) 699.24 ± 1.22 720.54 ± 1.21 639.06 ± 1.19 <0.001 <0.001
TNF-α (pg/ml) 44.26 ± 1.28 45.15 ± 1.02 32.46 ± 1.63 <0.001 <0.001
IL-6 (pg/ml) 52.46 ± 1.26 54.05 ± 1.25 43.38 ± 1.26 <0.001 <0.001
Serum
IL-1β (pg/ml) 21.76 ± 2.51 21.54 ± 2.66 14.59 ± 3.13 0.002 0.004
β-glucuronidase (U/L) 361.41 ± 1.67 368.71 ± 1.70 320.54 ± 1.63 0.053 0.037
TNF-α (pg/ml) 23.34 ± 2.56 24.53 ± 2.51 15.18 ± 3.94 0.005 0.003
IL-6 (pg/ml) 18.92 ± 1.97 18.73 ± 2.01 16.12 ± 2.18 0.052 0.092
*t-test
acomparison between women with overall periodontal disease and non-periodontal disease
bcomparison between women with moderate/severe periodontal disease and non-periodontal disease
Table 4 Crude and Adjusted Ratio of mean levels of inflammatory mediators in women with overall periodontal disease and
women with moderate or severe periodontal disease compared with women without periodontal disease
Inflammatory mediator Women with overall periodontal disease versus
without periodontal disease (mean ± SD)
N = 533
Women with moderate/severe periodontal disease
versus without periodontal disease (mean ± SD)
N = 338
Crude ratio Adjusted ratioa P Crude ratio Adjusted ratioa P
Saliva
IL-1β (pg/ml) 1.23 1.23 <0.001 1.26 1.25 <0.001
β-glucuronidase (U/L) 1.09 1.10 <0.001 1.13 1.13 <0.001
TNF-α (pg/ml) 1.36 1.36 <0.001 1.39 1.40 <0.001
IL-6 (pg/ml) 1.21 1.21 <0.001 1.25 1.25 <0.001
Serum
IL-1β (pg/ml) 1.49 1.49 <0.001 1.48 1.50 0.001
β-glucuronidase (U/L) 1.13 1.12 0.048 1.15 1.15 0.025
TNF-α (pg/ml) 1.54 1.53 <0.001 1.62 1.62 <0.001
IL-6 (pg/ml) 1.17 1.18 0.039 1.16 1.17 0.077
P values are for adjusted ratios only
aMultivariable linear regression adjusted for women’s age, smoking, educational level, employment status, monthly family income, parity, family periodontal
disease history, oral health insurance, BMI, stress score, oral hygiene
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are associated with adverse pregnancy outcomes, in-
cluding first-trimester losses, preeclampsia and gesta-
tional diabetes mellitus, and preterm birth [24–27].
However, prospective study is needed to examine
whether women with periodontal disease and high in-
flammatory concentrations are at higher risk to develop
adverse pregnancy outcomes. Our results also might in-
dicate that an existing inflammatory response would
render a woman more vulnerable to periodontal dis-
ease, similar to the interplay between diabetes and peri-
odontal disease [28].
Our findings were consistent with the studies by
Miller et al. and Ebersole et al. who also reported a sig-
nificantly higher mean level of saliva IL-1β, IL-6 in the
saliva and IL-1β and TNF-α in serum of people with
periodontal disease [7, 29, 30], but our findings differ
from the research conducted by Teles et al. and de
Queiroz et al. [31, 32], who did not find a statistically
significant differences of inflammatory mediators in
saliva or in serum between people with periodontal dis-
ease and without periodontal disease. However, most of
these studies had a relatively small sample size, usually
less than 50 in the group with periodontal disease, which
might led to the inadequate power to detect the diffe-
rence. In addition, as Teleset al. has pointed out, the
different methods of saliva collection, storage and lab
testing in each study could possibly result in the diffe-
rent findings [31].
Our study included a relatively larger sample size than
previously published studies in which patients with
periodontal disease numbered less than 100 [7, 29, 32].
We analyzed the both saliva and serum samples to exam-
ine the association between inflammation response and
periodontal disease. We chose saliva samples to reflect
periodontal health instead of gingival crevicular fluid due
to the convenient and simple collection process for saliva.
In addition, the purpose of our study was to explore the
degrees of host-derived inflammatory response. Saliva can
reflect the overall periodontal health of the patient, rather
a single point in the mouth [33, 34].
Weaknesses of the study included the high percentage
of women of good social economic status and high edu-
cation level among study population, which might result
in the selection bias and limit the generalizability of the
findings. Due to the limited funding, biological samples
were notable to be analyzed in duplicate. The mediators
chosen in this study were relevant both to the adverse
pregnancy outcomes and periodontal disease [9, 24–27],
but the involvement of mediators more specific to peri-
odontal disease, such as matrix metalloproteinase-8 in
both saliva and serum, should be considered in the fu-
ture studies. The use of oral contraceptive before the re-
cruitment was not recorded. Future studies should
measure an oral health index to more thoroughly reflect
oral health status.
Conclusion
Our study demonstrated that periodontal disease is highly
associated with the elevated levels of inflammatory media-
tors in saliva and some mediators in serum among pre-
conception women. Further studies involving more specific
mediators of periodontal disease are needed for explaining
the association between periodontal disease and systemic
inflammatory response before and during pregnancy.
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